WO2023144404 - NOVEL INTEGRIN ASSOCIATED PROTEIN (IAP)
National phase entry is expected:
Publication Number
WO/2023/144404
Publication Date
03.08.2023
International Application No.
PCT/EP2023/052233
International Filing Date
31.01.2023
Title **
[English]
NOVEL INTEGRIN ASSOCIATED PROTEIN (IAP)
[French]
NOUVELLE PROTÉINE ASSOCIÉE AUX INTÉGRINES (IAP)
Applicants **
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
Inventors
YANG, Che
Novo Alle 1
2880 Bagsværd, DK
Priority Data
22154167.5
31.01.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1168 | |
| EPO | Filing, Examination | 4790 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 9832 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to novel Integrin associated proteins, cells, compositions, and pharmaceutical products which improve the success of cellular therapy.[French]
La présente invention concerne de nouvelles protéines associées aux intégrines, des cellules, des compositions et des produits pharmaceutiques qui permettent d'améliorer la réussite d'une thérapie cellulaire.